Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Homo sapiens | thyroid stimulating hormone receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.2415 | 0.4403 |
Schistosoma mansoni | thyroid hormone receptor | 0.0159 | 0.5486 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.2415 | 0.2415 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.028 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2415 | 0.4403 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2415 | 0.4403 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.2297 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.2297 | 0.4187 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.2297 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2415 | 0.4403 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.2297 | 0.5 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0012 | 0 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.2415 | 0.4787 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2415 | 0.4403 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0147 | 0.5045 | 1 |
Onchocerca volvulus | 0.0012 | 0 | 0.5 | |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0012 | 0 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.2415 | 0.2415 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.2415 | 0.2415 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2415 | 0.4403 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0073 | 0.2297 | 0.5 |
Schistosoma mansoni | thyroid hormone receptor | 0.0159 | 0.5486 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.2415 | 0.2415 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0147 | 0.5045 | 0.9197 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0012 | 0 | 0.5 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0159 | 0.5486 | 1 |
Brugia malayi | RNA binding protein | 0.0076 | 0.2415 | 0.2415 |
Schistosoma mansoni | hypothetical protein | 0.0147 | 0.5045 | 0.9197 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.2297 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.2415 | 0.2415 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.2297 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.2297 | 0.4187 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.2297 | 0.4187 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.2297 | 0.4552 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.6169 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.